semaglutide and metronidazole Receives FDA Approval for Treatment of MASH Semaglutide Wegovy® - Tablet -

Severe or persistent vomiting is a red flag

Dose reductions or discontinuation of valproate should be considered in patients with decreased food or fluid intake and in patients with excessive somnolence

Associated neuroendocrine changes, including elevated cortisol and reduced growth hormone, further compromise erectile physiology [24]

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved both medications for use in type 2 diabetes, and prescribing information for each drug acknowledges their potential use alongside other glucose-lowering therapies

In the current analysis, they saw no discernible effects on markers of subclinical vascular disease (including endothelial function and arterial stiffness) or calcified atherosclerotic plaque